Millstone Evans Group, LLC Merck & Co., Inc. Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q1 2025
A detailed history of Millstone Evans Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Millstone Evans Group, LLC holds 13,023 shares of MRK stock, worth $1.08 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
13,023
Previous 13,181
1.2%
Holding current value
$1.08 Million
Previous $1.31 Billion
10.85%
% of portfolio
0.79%
Previous 0.89%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,899Shares Held
1.86BCall Options Held
16.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.07 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.66 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...